share_log

兄弟科技(002562.SZ):制剂在研产品聚焦神经、代谢、免疫、呼吸等治疗领域

Brother Technology (002562.SZ): Formulation products under development focus on neurological, metabolic, immune, respiratory and other therapeutic fields

Gelonghui Finance ·  Jan 12 04:35

Gelonghui, January 12: An investor asked Brother Technology (002562.SZ) on the investor interactive platform, “What are the company's formulation products being developed”. The company replied that the company's formulations focus on neurological, metabolic, immune, and respiratory treatments.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment